Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from CellSource Co., Ltd. ( (JP:4880) ).
CellSource Co., Ltd. has received approval from the Tokyo Stock Exchange to transfer its listing from the Prime Market to the Standard Market, effective March 24, 2026, after failing to meet the Prime segment’s tradable share market capitalization requirement as of October 31, 2025. With this move, the company is withdrawing its previously announced plan to restore compliance with Prime Market criteria and instead will focus on strengthening profitability and linking business growth to long-term corporate value under the Standard Market’s governance and liquidity framework, while emphasizing continued commitment to regenerative medicine and meeting stakeholder expectations.
Management presented the transition as a strategic step that aligns listing requirements with the company’s current market profile, potentially easing the pressure of Prime-level thresholds while still maintaining access to public capital markets. By prioritizing cost-of-capital-conscious growth and profitability improvements in the Standard Market, CellSource aims to stabilize its listing status and reassure shareholders and investors of its intention to deliver sustainable value over the medium to long term.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen377.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
CellSource Co., Ltd. is a Japan-based company operating in the regenerative medicine field, focused on the social implementation of regenerative therapies and related services. Listed on the Tokyo Stock Exchange, the company targets sustainable growth by balancing business expansion with governance, liquidity and an awareness of capital costs to enhance medium- to long-term corporate value.
Average Trading Volume: 104,577
Technical Sentiment Signal: Sell
Current Market Cap: Yen7.58B
For a thorough assessment of 4880 stock, go to TipRanks’ Stock Analysis page.